HuGE Literature Finder
Records 1-9
|
KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients.
Oncotarget 2018 Apr 9 (28): 19650-19661. Saito Hiromi, Umemura Takeji, Joshita Satoru, Yamazaki Tomoo, Fujimori Naoyuki, Kimura Takefumi, Komatsu Michiharu, Matsumoto Akihiro, Tanaka Eiji, Ota Mas |
|
Genetic diversity of the KIR/HLA system and susceptibility to hepatitis C virus-related diseases.
PloS one 2015 10 (2): e0117420. De Re Valli, Caggiari Laura, De Zorzi Mariangela, Repetto Ombretta, Zignego Anna Linda, Izzo Francesco, Tornesello Maria Lina, Buonaguro Franco Maria, Mangia Alessandra, Sansonno Domenico, Racanelli Vito, De Vita Salvatore, Pioltelli Pietro, Vaccher Emanuela, Berretta Massimiliano, Beretta Massimiliano, Mazzaro Cesare, Libra Massimo, Gini Andrea, Zucchetto Antonella, Cannizzaro Renato, De Paoli Pao |
|
Association of killer cell immunoglobulin-like receptor polymorphisms with chronic hepatitis C and responses to therapy in Brazil.
Genetics and molecular biology 2013 Mar 36 (1): 22-7. de Vasconcelos Janaina Mota, de Jesus Maués Pereira Móia Lizomar, Amaral Ivanete do Socorro Abraçado, Miranda Esther Castello Branco Mello, Cicalisetakeshita Louise Yukari, de Oliveira Layanna Freitas, de Araújo Melo Mendes Lilian, Sastre Danuta, Tamegão-Lopes Bruna Pedroso, de Aquino Pedroza Larysse Santa Rosa, Batista Dos Santos Sidney Emanuel, Soares Manoel do Carmo Pereira, de Araújo Marialva Tereza Ferreira, Bandeira Camila Lucas, de Sousa da Silva Adriana Maria Paixão, de Medeiros Zilene Lameira, Sena Leonardo, Demachki Samia, Dos Santos Eduardo José Me |
|
KIR, HLA, and IL28B variant predict response to antiviral therapy in genotype 1 chronic hepatitis C patients in Japan.
PloS one 2013 8 (12): e83381. Nozawa Yuichi, Umemura Takeji, Joshita Satoru, Katsuyama Yoshihiko, Shibata Soichiro, Kimura Takefumi, Morita Susumu, Komatsu Michiharu, Matsumoto Akihiro, Tanaka Eiji, Ota Mas |
|
Killer cell immunoglobulin-like receptors and response to antiviral treatment in Thai patients with chronic hepatitis C virus genotype 3a.
Journal of medical virology 2011 Oct 83 (10): 1733-7. Vejbaesya Sasijit, Nonnoi Yuwatida, Tanwandee Tawesak, Srinak Duangpo |
|
Effect of killer immunoglobulin-like receptors in the response to combined treatment in patients with chronic hepatitis C virus infection.
Journal of virology 2010 Jan 84 (1): 475-81. Vidal-Castiñeira J R, López-Vázquez A, Díaz-Peña R, Alonso-Arias R, Martínez-Borra J, Pérez R, Fernández-Suárez J, Melón S, Prieto J, Rodrigo L, López-Larrea |
|
Lack of killer immunoglobulin-like receptor 2DS2 (KIR2DS2) and KIR2DL2 is associated with poor responses to therapy of recurrent hepatitis C virus in liver transplant recipients.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2009 Nov 15 (11): 1557-63. Askar Medhat, Avery Robin, Corey Rebecca, Lopez Rocio, Thomas Dawn, Pidwell Diane, Eghtesad Bijan, Miller Charles, Fung John, Zein Nizar |
|
Protective KIR-HLA interactions for HCV infection in intravenous drug users.
Molecular immunology 2009 Aug 46 (13): 2723-7. Zúñiga Joaquín, Romero Viviana, Azocar José, Terreros Daniel, Vargas-Rojas María Inés, Torres-García Diana, Jiménez-Alvarez Luis, Vargas-Alarcón Gilberto, Granados-Montiel Julio, Husain Zaheed, Chung Raymond T, Alper Chester A, Yunis Edmond |
|
HLA-C and KIR genes in hepatitis C virus infection.
Human immunology 2005 Nov 66 (11): 1106-9. Montes-Cano Marco Antonio, Caro-Oleas José Luis, Romero-Gómez Manuel, Diago Moisés, Andrade Raul, Carmona Isabel, Aguilar Reina José, Núñez-Roldán Antonio, González-Escribano María Francis |
- Page last reviewed:Oct 1, 2020
- Page last updated:Dec 03, 2020
- Content source: